.svg)
Mountain Valley MD Investor
CEO Updates
May 8, 2023
// CEO Update
MVMD Executes Soluvec™ License Agreement, Completes Studies, Expands IP Protection
View UpdateView UpdateSeptember 13, 2022
// CEO Update
MVMD Commences Commercial Sales of Agrarius Agro Plant Stimulant
View UpdateView UpdateJune 27, 2022
// CEO Update
MVMD Successfully Completes Soluvec™ Pharmacokinetic Study
View UpdateView UpdateMay 20, 2022
// CEO Update
MVMD Interview with Gokul Kannan at Stanford University
View UpdateView UpdateMarch 16, 2022
// CEO Update
MVMD Welcomes Dr. Elizabeth Norton to Advisory Role / Cold Chain and Vaccine Progress
View UpdateView UpdateSeptember 29, 2021
// CEO Update
MVMD Agreement with Red White & Bloom / AGM Business Presentation Video
View UpdateView UpdateSeptember 25, 2021
// CEO Update
Register for MVMD AGM – Wednesday, September 29th
View UpdateView UpdateJuly 14, 2021
// CEO Update
MVMD Coverage in Forbes – “This Entrepreneur Is On A Mission To Tackle Global Health Challenges”
View UpdateView UpdateJuly 7, 2021
// CEO Update
MVMD Announces Results from FDA Cold Chain Evaluation
View UpdateView UpdateJune 24, 2021
// CEO Update
MVMD Update: FDA, Oncology, Cold Chain, Husbandry and more
View UpdateView UpdateMay 25, 2021
// CEO Update
MVMD to host live, virtual Q&A session with CEO on Wednesday, May 26 at 11am
View UpdateView UpdateMay 18, 2021
// CEO Update
MVMD Confirms Ivectosol™ Clears COVID-19 on all Three Variants Tested in BSL-4 Lab
View UpdateView UpdateMay 3, 2021
// CEO Update
MVMD Announces Pre-Clinical Cancer Trials and Related Cancer Patent Filing
View UpdateView UpdateApril 20, 2021
// CEO Update
MVMD Proceeding with TSX Venture Exchange Application
View UpdateView UpdateMarch 16, 2021
// CEO Update
MVMD Commencing Trials in Bangladesh, Striking Pharma Partnership Agreements
View UpdateView UpdateMarch 10, 2021
// CEO Update
MVMD Achieves Solubilization of Selemectin Drug, Files New Trademark
View UpdateView UpdateMarch 3, 2021
// CEO Update
MVMD Proceeding with FDA 505(b)(2) Pathway Application + Trial Updates
View UpdateView UpdateMarch 1, 2021
// CEO Update
MVMD Commencing Husbandry Animal Clinical Trials, Appoints Dr. of Veterinary Medicine to Advisory Board
View UpdateView UpdateFebruary 25, 2021
// CEO Update
MVMD Completes Quicksome™ License Agreement with Mushroom Partner
View UpdateView UpdateFebruary 22, 2021
// CEO Update
MVMD Testing South African COVID-19 Variant in Upcoming BSL-4 Clearance Trial
View UpdateView UpdateFebruary 22, 2021
// CEO Update
MVMD – Mike Farber Interview on South African Variant News
View UpdateView UpdateFebruary 15, 2021
// CEO Update
MVMD News Coverage and CEO Interview on The Dales Report
View UpdateView UpdateFebruary 11, 2021
// CEO Update
Mountain Valley MD story gaining global attention with interview coverage in South Africa’s BizNews
View UpdateView UpdateDecember 22, 2020
// CEO Update
New MVMD CEO Interview, Oversubscription of Private Placement
View UpdateView UpdateDecember 18, 2020
// CEO Update
MVMD Interview Update - Mike Farber, Director of Life Sciences
View UpdateView UpdateDecember 16, 2020
// CEO Update
MVMD CEO Interview on Proactive Investor this Morning
View UpdateView UpdateDecember 14, 2020
// CEO Update
MVMD Advisory Board Growth and Strategic Investment
View UpdateView UpdateDecember 10, 2020
// CEO Update
MUST WATCH – ARE YOU WITH US? MVMD: Infinite Possibility
View UpdateView UpdateDecember 9, 2020
// CEO Update
MUST WATCH (video link) - Ivermectin Validation in COVID-19 Therapies!
View UpdateView UpdateNovember 25, 2020
// CEO Update
MVMD Secures Quicksome™ License Agreement with Mushroom Partner and Strategic Sale of Subsidiary
View UpdateView UpdateNovember 11, 2020
// CEO Update
Mountain Valley MD confirms major breakthrough in solubilizing ivermectin, files patents to protect IP and related COVID-19 applications
View UpdateView UpdateOctober 2, 2020
// CEO Update
